跳至主要内容
临床试验/JPRN-UMIN000040914
JPRN-UMIN000040914招募中未知

Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer - Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer

Department of Urology, Gunma University Graduate School of Medicine0 个研究点目标入组 160 人开始时间: 2020年7月31日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1 Epileptic state patients 2 Brain damage, apoplexy, brain metastatis, active epidural metastatis of cranium 3 Hypersensitivity to darolutamide or its component 4 Severe liver dysfunction 5 Severe kidney function 6 Cases with distant metastases at the first visit 7 Impropriate state judged by charged doctor

研究者

发起方
Department of Urology, Gunma University Graduate School of Medicine

相似试验